相关实验视频

Updated: Jun 29, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

血栓微环境响应性交叉链接循环德克斯特林金属有机框架纳米载体用于精确准和血栓溶解

Caijie Yuan¹, Yaxin Ye¹, Enling Hu¹

¹State Key Laboratory of Laboratory of Resource Insects, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing 400715, China; Chongqing Engineering Research Center of Biomaterial Fiber and Modern Textile, Chongqing 400715, China.

Carbohydrate polymers

|March 29, 2024

概括

一种新的药物输送系统向血栓,释放尿激酶类型的血原激活剂和阿司匹林来溶解血块和减少炎症,提高血栓性疾病的安全性和疗效.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
药理学药理学是指药理学的学科.

背景情况:

由于高死亡率和残疾率,血栓性疾病对全球健康构成重大威胁.
现有的血栓溶解剂通常具有短的循环半衰期,限制了它们的治疗效果.
针对性的药物输送系统对于在血栓部位准确和规范地释放治疗药物至关重要.

研究的目的:

开发一种智能药物输送系统 (MCRUA),用于向血栓溶解.
为了实现由血栓微环境触发的精确药物释放.
结合血栓解消和抗炎作用,以增强血栓性疾病的治疗.

主要方法:

开发一个金属有机框架 (MC) 系统,载有尿素酶类型的血原激活剂 (uPA) 和阿司匹林 (ASA).
用c ((RGD) 对血小板向的MC表面的功能化.
利用pH敏感的CaCO3 / 循环德克斯特林交叉链接在酸性血栓环境中控制药物释放.

主要成果:

该MCRUA系统选择性地准血小板,并在酸性血栓微环境中分解.
控制释放的uPA促进血栓溶解和血管再通道.
封装的ASA减少炎症并增强抗血小板聚合,支持合作疗法.

结论:

在MCRUA药物输送系统有效地促进血栓溶解,并抑制血栓性疾病中的转血栓形成.
该系统提供了增强的生物安全性,降低了出血副作用的风险.
对于先进的,有针对性的血栓状况治疗,MCRUA是一个有前途的战略.

关键词:

抗血小板聚合的抗血小板聚合.循环德克斯特林 (Cyclodextrin) 是一种循环德克斯特林.MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF MOF 目标化效应的目标化效应血栓溶解是一种血栓溶解.响应pH的pH值的响应

更多相关视频

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

相关概念视频

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...